Lancashire and South Cumbria
Formulary
Formulary
6 Endocrine system
06-01-01-02 Biphasic insulins
| Humulin® M3 Biphasic Isophane Insulin |
|
Formulary
|
10mL vial First line biphasic human insulin (Humulin M3 Kwikpen) |
|
| NovoMix® 30 Biphasic Insulin Aspart |
|
Formulary
|
3mL cartridge for Innovo® or NovoPen® First line biphasic short-acting analogue insulin (Novomix 30 Flexpen) |
|
|
Links
Diabetes UK: Diabetes when you’re unwell
LSCMMG: GLP-1 patient contract
LSCMMG: Guideline for antihyperglycaemic therapy in adults with type 2 diabetes- LSCMMG: Guideline for antihyperglycaemic therapy in adults with type 2 diabetes
- LSCMMG: Guideline for antihyperglycaemic therapy in adults with type 2 diabetes
- LSCMMG: Guidelines for the Home Monitoring of Blood Glucose Levels
- LSCMMG: Insulin degludec plus liraglutide
- LSCMMG: Insulin Toujeo® SoloStar® DoubleStar® Product Information Sheet & Good Practice Guide
- LSCMMG: Lancashire and South Cumbria ICB recommended meters, strips and devices Dec 2023
- LSCMMG: Policy for Continuous Glucose Monitoring and Flash Glucose Monitoring to patients with Diabetes Mellitus
- LSCMMG: Policy for the Provision of Insulin Pumps for Patients with Diabetes Mellitus
- LSCMMG: Trans Female Gender Dysphoria Information Sheet
- LSCMMG: Trans Male Gender Dysphoria Information Sheet
- LSCMMG:Guideline for antihyperglycaemic therapy in adults with type 2 diabetes
- MHRA Drug Safety Update June 2019: GLP-1 receptor agonists: reports of diabetic ketoacidosis when concomitant insulin was rapidly reduced or discontinued
- MHRA safety alert on availability of 2 strengths
- MHRA: Diabetes and driving
- NICE NG17: Type 1 diabetes in adults: diagnosis and management
- NICE NG18: Diabetes (type 1 and type 2) in children and young people: diagnosis and management
- NICE NG19: Diabetic foot problems: prevention and management
- NICE NG28: Type 2 diabetes in adults: management
- NICE NG3: Diabetes in pregnancy: management from preconception to the postnatal period